Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/21/2902250/0/en/Lexicon-Pharmaceuticals-Resubmits-Sotagliflozin-NDA-for-Type-1-Diabetes.html
https://www.globenewswire.com/news-release/2024/06/19/2901068/0/en/Data-From-Lexicon-s-RELIEF-DPN-1-Phase-2-Study-of-LX9211-Published-Today-in-Diabetes-Care-a-Peer-Reviewed-Journal-of-the-American-Diabetes-Association.html
https://www.globenewswire.com/news-release/2024/06/18/2900345/0/en/Analysis-of-INPEFA-Sotagliflozin-Cost-Effectiveness-Published-in-JACC-Heart-Failure-the-Peer-Reviewed-Journal-of-the-American-College-of-Cardiology.html
https://www.globenewswire.com/news-release/2024/06/14/2898946/0/en/Findings-on-the-Burdens-of-Diabetic-Peripheral-Neuropathic-Pain-DPNP-Among-Three-Lexicon-Sponsored-Presentations-at-the-84th-Scientific-Sessions-of-the-American-Diabetes-Associatio.html
https://www.globenewswire.com/news-release/2024/05/29/2889736/0/en/Lexicon-Pharmaceuticals-to-Participate-in-the-Jefferies-Global-Healthcare-Conference-2024.html
https://www.globenewswire.com/news-release/2024/05/14/2881207/0/en/New-Post-Hoc-Analysis-of-Pooled-Phase-3-Data-Shows-That-INPEFA-Sotagliflozin-Reduced-Risk-of-Heart-Failure-Events-in-Patients-With-Preserved-Ejection-Fraction.html
https://www.globenewswire.com/news-release/2024/05/09/2878651/0/en/Lexicon-Pharmaceuticals-to-Participate-in-the-Bank-of-America-Securities-Healthcare-Conference-2024.html
https://www.globenewswire.com/news-release/2024/05/02/2874675/0/en/Lexicon-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/29/2871084/0/en/Lexicon-Pharmaceuticals-to-Host-First-Quarter-2024-Financial-Results-Conference-Call-and-Webcast-on-May-2-2024.html